Takeda: all 1,753 studies

Page 11 of 18. Open to participants first (93), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults.CompletedNCT00744627Phase 3Results posted
• Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT00735709Phase 3Results posted
• Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT00735371Phase 3Results posted
• Efficacy and Safety of SPD503 in Combination With PsychostimulantsCompletedNCT00734578Phase 3Results posted
• An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety DisorderCompletedNCT00734071Phase 3Results posted
• Use of NPSP558 in the Treatment of HypoparathyroidismCompletedNCT00732615Phase 3Results posted
• Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety DisorderCompletedNCT00731120Phase 3Results posted
• Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety DisorderCompletedNCT00730691Phase 3Results posted
• Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.CompletedNCT00727857Phase 3Results posted
• A Study of Subcutaneous and Intravenous VELCADE in Patients With Previously Treated Multiple MyelomaCompletedNCT00722566Phase 3Results posted
• Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell LymphomaCompletedNCT00722137Phase 3Results posted
• Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular LymphomaCompletedNCT00715208Phase 2Results posted
• Evaluation of TachoSil® Application on a Colorectal Anastomosis (TC-029-IM)CompletedNCT00713661Phase 2Results posted
• The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)TerminatedNCT00713258Phase 4Results posted
• Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.CompletedNCT00708175Phase 4Results posted
• Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly DiabeticsCompletedNCT00707993Phase 3Results posted
• Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT00707980Phase 3Results posted
• Non-Interventional Study About Treatment of Hemorrhages in Thyroid Surgery With TachoSil®CompletedNCT00700141Results posted
• Matrifen® for Therapy of Severe Chronic Pain®CompletedNCT00699335Results posted
• Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)CompletedNCT00697515Phase 3Results posted
• Study of MLN8237 in Participants With Advanced Hematological MalignanciesCompletedNCT00697346Phase 1Results posted
• An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.CompletedNCT00696436Phase 3Results posted
• A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential HypertensionCompletedNCT00696384Phase 3Results posted
• Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential HypertensionCompletedNCT00696241Phase 3Results posted
• One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential HypertensionCompletedNCT00695955Phase 3Results posted
• Open-Label Extension Study of Recombinant Human Arylsulfatase A (HGT-1111) in Late Infantile MLDTerminatedNCT00681811Phase 2Results posted
• Guanfacine Immediate-release Electrocardiogram Results (QTc) StudyCompletedNCT00672984Phase 1Results posted
• Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive DisorderCompletedNCT00672958Phase 3Results posted
• Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive DisorderCompletedNCT00672620Phase 3Results posted
• Pharmacokinetic Comparison of Advate rAHF-PFM With Recombinate rAHF in Patients With Severe Hemophilia ACompletedNCT00666406Phase 4Results posted
• Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor NeuropathyCompletedNCT00666263Phase 3Results posted
• DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)TerminatedNCT00664066Results posted
• Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.CompletedNCT00655863Phase 3Results posted
• A Phase I Clinical and Pharmacodynamic Study of MLN8237, A Novel Aurora A Kinase Inhibitor, in Participants With Advanced MalignanciesCompletedNCT00651664Phase 1Results posted
• A Phase II Study of VELCADE (Bortezomib) in Combination With Bendamustine and Rituximab in Subjects With Relapsed or Refractory Follicular LymphomaCompletedNCT00636792Phase 2Results posted
• An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher DiseaseCompletedNCT00635427Phase 3Results posted
• Efficacy and Safety of Resatorvid in Patients With Sepsis-induced Cardiovascular and Respiratory FailureTerminatedNCT00633477Phase 3Results posted
• Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)CompletedNCT00633139Phase 1/2Results posted
• Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving IdursulfaseCompletedNCT00630747Phase 2/3Results posted
• A Study of Dexlansoprazole Modified Release Formulation to Treat Night HeartburnCompletedNCT00627016Phase 3Results posted
• Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's DiseaseCompletedNCT00619489Phase 2Results posted
• An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib)CompletedNCT00608907Phase 1Results posted
• Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase TherapyCompletedNCT00607386Phase 4Results posted
• Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase SyndromeCompletedNCT00593736Phase 2Results posted
• Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential HypertensionCompletedNCT00591773Phase 3Results posted
• Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential HypertensionCompletedNCT00591578Phase 3Results posted
• Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential HypertensionCompletedNCT00591266Phase 3Results posted
• Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential HypertensionCompletedNCT00591253Phase 3Results posted
• Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other TreatmentsCompletedNCT00567502Results posted
• Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS)CompletedNCT00562094Results posted
• Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD)CompletedNCT00561730Results posted
• Long-term Effect of Lanthanum Carbonate on BoneCompletedNCT00557323Results posted
• Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic HypotensionCompletedNCT00555880Phase 4Results posted
• Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher DiseaseCompletedNCT00553631Phase 3Results posted
• Comparison of Intravenous and Subcutaneous Administration of IGIV, 10% in Primary Immunodeficiency (PID) SubjectsCompletedNCT00546871Phase 2/3Results posted
• Prevention of Recurrence of DiverticulitisCompletedNCT00545740Phase 3Results posted
• Prevention of Recurrence of DiverticulitisCompletedNCT00545103Phase 3Results posted
• A Study to Evaluate Two Different Regimens of VELCADE in Combination With Dexamethasone, Thalidomide and Cyclophosphamide (VDT vs VDTC) in Newly Diagnosed Multiple MyelomaCompletedNCT00531453Phase 2Results posted
• Dynepo Long-Term Safety StudyTerminatedNCT00514813Phase 4Results posted
• Phase 1/2 Study of VELCADE® in Combination With Other Drugs to Treat Previously Untreated Multiple Myeloma PatientsCompletedNCT00507442Phase 1/2Results posted
• Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and PrednisoneCompletedNCT00507416Phase 3Results posted
• MPC-004 for the Treatment of an Acute Gout FlareCompletedNCT00506883Phase 3Results posted
• A Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Participants With Advanced Solid TumorsCompletedNCT00500903Phase 1Results posted
• Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE)CompletedNCT00500656Phase 3Results posted
• A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)CompletedNCT00500149Phase 3Results posted
• Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHDCompletedNCT00500071Phase 4Results posted
• Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant RecipientsCompletedNCT00497796Phase 3Results posted
• Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic InsomniaCompletedNCT00492232Phase 4Results posted
• Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)CompletedNCT00479037Phase 4Results posted
• Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With ImigluceraseCompletedNCT00478647Phase 2/3Results posted
• Adherence to PTH(1-84) Treatment (FP-002-IM)CompletedNCT00478569Results posted
• Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) AttacksCompletedNCT00462709Phase 3Results posted
• Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)CompletedNCT00457015Phase 3Results posted
• Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)CompletedNCT00456508Phase 3Results posted
• Dynepo Infrequent Dosing StudyTerminatedNCT00450333Phase 3Results posted
• Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC)CompletedNCT00446849Phase 4Results posted
• Head to Head Study Against Sevelamer HydrochlorideCompletedNCT00441545Phase 3Results posted
• TachoSil® Versus Standard Haemostatic Treatment of Haemorrhage in Cardiovascular Surgery (TC-023-IM)CompletedNCT00440401Phase 4Results posted
• Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) AttacksCompletedNCT00438815Phase 3Results posted
• Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes MellitusCompletedNCT00432276Phase 3Results posted
• A Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Gaucher DiseaseCompletedNCT00430625Phase 3Results posted
• Efficacy and Safety of Oral Febuxostat in Participants With GoutCompletedNCT00430248Phase 3Results posted
• Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)CompletedNCT00418561Phase 1Results posted
• RCT of ChondroCelect® (in an ACI Procedure) vs Microfracture in the Repair of Cartilage Defects of the KneeCompletedNCT00414700Phase 3Results posted
• The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET)CompletedNCT00413634Phase 2Results posted
• Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant RecipientsCompletedNCT00411645Phase 3Results posted
• Evaluation of Safety and Activity of Celaderm in Healing Venous Leg UlcersCompletedNCT00399308Phase 1/2Results posted
• Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor)CompletedNCT00396006Phase 4Results posted
• Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes MellitusCompletedNCT00395512Phase 3Results posted
• Open-Label Extension Study Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX008A (ERT)CompletedNCT00391625Phase 1/2Results posted
• SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional SymptomsCompletedNCT00367835Phase 3Results posted
• Sequential Treatment of Postmenopausal Women With Primary Osteoporosis (FP-001-IM)CompletedNCT00365456Phase 3Results posted
• Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate HypertensionCompletedNCT00362115Phase 2Results posted
• Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic SurgeryCompletedNCT00357656Phase 4Results posted
• An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00337285Phase 3Results posted
• Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.CompletedNCT00328627Phase 3Results posted
• Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux DiseaseCompletedNCT00321984Phase 3Results posted
• Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive EsophagitisCompletedNCT00321737Phase 3Results posted
• Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney DiseaseCompletedNCT00314795Phase 2Results posted
• Aralast alpha1-proteinase Inhibitor Surveillance StudyTerminatedNCT00313144Phase 4Results posted

← Takeda overview and focus areas